TO THE EDITOR
Human herpesvirus 8 (HHV-8) or Kaposi's sarcoma-associated herpesvirus (KSHV), a human rhadinovirus, is the etiological agent of all forms of Kaposi's sarcoma. It is also associated to primary effusion lymphoma (PEL), a rare form of malignant clonal B-cell lymphoproliferation, occurring mostly in HIV-1-infected patients, and to some aggressive cases of multicentric Castleman disease (MCD), a polyclonal B-cell proliferation with specific pathological features.
Recently, several lines of evidence have associated HHV-8 infection to the plasma-cell lineage. (1) Gene expression profile of PEL is similar to that of transformed plasma cells.
1 ( 2) The micro-lymphomas associated with MCD are plasmablastic polyclonal proliferations.
2 (3) Evolution of some of these rare MCD-associated lymphomas is marked by a fulminant leukemic phase of plasmablastic cells infected by HHV-8 and expressing HHV-8 latent nuclear antigen.
3 (4) An unusual case of plasmacell leukemia with Hepatitis C virus (HCV) and HHV-8 coinfection has been reported. 4 To gain insight into the link between HHV-8 and B cells of the plasma-cell lineage, we searched for HHV-8 infection in a series of 25 samples of blood, bone marrow or pleural liquid proliferations of plasma cells including plasma-cell leukemia (12 cases), myeloma (six cases), lymphoplasmocytic lymphoma (three cases), idiopathic lymphoplasmocytosis (three cases) and Waldenström disease (one case). All the 12 plasma-cell leukemias studied were defined by the presence of an absolute plasma-cell count 42.10 9 /l, showing an intense positivity for the CD38 marker and, when also performed, for the CD138 marker.
High molecular weight DNA was extracted from the 25 tumoral samples using a classical phenol/chloroform method. All DNA samples were first amplified by polymerase chain reaction (PCR) for human b-globin sequences to control the integrity and amplifiability of the DNAs. Then, search for HHV-8 infection was performed by PCR with two sets of primers targeting the HHV-8 orf26 and orf75, as previously described. 5 All the DNAs, but two, yielded negative results for HHV-8 by PCR and Southern blot hybridization using two specific internal radio-labeled probes. The two positive samples, with both primer sets, originate from two HIV-negative patients. The first one was a French causasian woman (81-year old) with a de novo plasma-cell leukemia, while the second one was a French caucasian male (61-year old) suffering from a plasma-cell leukemia occurring after a bone marrow transplantation performed for a myeloma.
Real-time (TaqMan) quantitative PCR was also performed, as described, 6 on the 25 DNAs and, as expected, the only two same samples were positive with a very low viral copy number (0.004 copy per cell ¼ 660 HHV-8 copies/mg of DNA for both samples). In our experience, such viral load is similar to what is found in the peripheral blood mononuclear cells (PBMCs) of the few healthy HHV-8 seropositive persons with detectable viral load in the PBMCs. Thus, these results suggest that either HHV-8 is not present in the tumoral cells of these two patients, but in some normal B circulating infected cells (considered as the reservoir of peripheral HHV-8), or that it is present only in a very small fraction of the tumoral cells. The latter situation is rather unlikely in a clonal population, but could not be formally eliminated.
Clonality is a central issue in understanding the pathogenesis of tumoral lymphoproliferations. We have recently demonstrated that the number of terminal repeats (TR) contained in the fused TR region of HHV-8 could be used as a marker of clonality in HHV-8-associated tumors. 7 A similar approach has previously been used for Epstein-Barr virus (EBV) to determine in vivo clonality of EBV-associated tumors as nasopharyngeal carcinomas and to show that EBV infection preceded the clonal expansion of Burkitt's lymphomas and non-Hodgkin's lymphomas. 8 However, as the size of the HHV-8 fused TR region (16-75 TR units of 800 bp each) is in vivo considerably higher than that of the EBV (1-9 TR units of 500 bp each), high-resolution pulsed-field gene electrophoresis (PFGE) is required to reliably assess the size heterogeneity of the HHV-8 fused TR region. 7 We applied this molecular technique to the tumoral DNA of the recently published case of a plasma-cell leukemia associated with both HHV-8 and HCV infection 4 but considered as a HCVdriven tumor (presence of a monoclonal IgG kappa directed against HCV core protein). This approach was only applicable to this case due to the high viral copy number previously estimated (about 300 viral copies per blast). Result of the PFGE followed by hybridization with a specific TR radio-labeled probe (Figure 1) indicates a clear hybridization signal with heterogeneous fused TR fragments. Indeed, this sample showed four TR bands ranging from 39.9 to 59.8 kb. The two major bands in size (around 59.6 and 59.8 kb) were of identical intensity, while the two others were of smaller intensity and size (39.9 and 44.6 kb).
The presence of an oligoclonal pattern in this monoclonal tumor, albeit surprising, is quite similar to what is observed in some PEL. 7 As discussed for PEL, several hypotheses can be raised, including among others: (1) occurrence of multiple infection events in a single tumor cell, or (2) presence of fused termini of linear concatameric replicative intermediates generated in replicative cells; however, there was no evidence of DNA ladder on the PFGE pattern, which indicates the absence of detectable ongoing lytic replication in these tumoral cells by this not very sensitive technique, as opposed to immunohistochemistry, or (3) integration of an HHV-8 fragment in the cellular genome. Ongoing studies are performed to get new insights into such different possibilities. In the studied case, and as previously suggested, 4 the initial expansion of the monoclonal tumoral population would have been initially driven, by HCV infection, then followed by multiple HHV-8 infection.
In conclusion, our findings suggest that HHV-8 infection does not play a direct role in the development of most of the plasmacell leukemias. However, this does not eliminate the possible role of HHV-8, either alone or in association with other lymphotropic viruses including HCV and EBV, in the development of some specific tumors of the plasma-cell lineage, especially in highly endemic areas or populations for these viruses. 
